1. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Issue 2 (29th June 2015) Authors: Hicks, JK; Bishop, JR; Sangkuhl, K; Müller, DJ; Ji, Y; Leckband, SG; Leeder, JS; Graham, RL; Chiulli, DL; LLerena, A; Skaar, TC; Scott, SA; Stingl, JC; Klein, TE; Caudle, KE; Gaedigk, A Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 2(2015:Aug.) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. Issue 2 (6th April 2017) Authors: Bell, GC; Caudle, KE; Whirl‐Carrillo, M; Gordon, RJ; Hikino, K; Prows, CA; Gaedigk, A; Agundez, JAG; Sadhasivam, S; Klein, TE; Schwab, M Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 2(2017) Page Start: 213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update. Issue 3 (4th April 2017) Authors: Johnson, JA; Caudle, KE; Gong, L; Whirl‐Carrillo, M; Stein, CM; Scott, SA; Lee, MT; Gage, BF; Kimmel, SE; Perera, MA; Anderson, JL; Pirmohamed, M; Klein, TE; Limdi, NA; Cavallari, LH; Wadelius, M Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 3(2017) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing. Issue 4 (9th November 2015) Authors: Gammal, RS; Court, MH; Haidar, CE; Iwuchukwu, OF; Gaur, AH; Alvarellos, M; Guillemette, C; Lennox, JL; Whirl‐Carrillo, M; Brummel, SS; Ratain, MJ; Klein, TE; Schackman, BR; Caudle, KE; Haas, DW Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 4(2016:Apr.) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy. Issue 1 (18th April 2017) Authors: Moriyama, B; Obeng, A Owusu; Barbarino, J; Penzak, SR; Henning, SA; Scott, SA; Agúndez, JAG; Wingard, JR; McLeod, HL; Klein, TE; Cross, SJ; Caudle, KE; Walsh, TJ Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 1(2017) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Issue 1 (3rd June 2015) Authors: Birdwell, KA; Decker, B; Barbarino, JM; Peterson, JF; Stein, CM; Sadee, W; Wang, D; Vinks, AA; He, Y; Swen, JJ; Leeder, JS; van Schaik, RHN; Thummel, KE; Klein, TE; Caudle, KE; MacPhee, IAM Journal: Clinical pharmacology & therapeutics Issue: Volume 98:Issue 1(2015:Jul.) Page Start: 19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update. Issue 1 (16th July 2015) Authors: Saito, Y; Stamp, LK; Caudle, KE; Hershfield, MS; McDonagh, EM; Callaghan, JT; Tassaneeyakul, W; Mushiroda, T; Kamatani, N; Goldspiel, BR; Phillips, EJ; Klein, TE; Lee, MTM Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 1(2016:Jan.) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Issue 1 (13th February 2017) Authors: Hicks, JK; Sangkuhl, K; Swen, JJ; Ellingrod, VL; Müller, DJ; Shimoda, K; Bishop, JR; Kharasch, ED; Skaar, TC; Gaedigk, A; Dunnenberger, HM; Klein, TE; Caudle, KE; Stingl, JC Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 1(2017) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Issue 4 (10th October 2017) Authors: Bank, PCD; Caudle, KE; Swen, JJ; Gammal, RS; Whirl‐Carrillo, M; Klein, TE; Relling, MV; Guchelaar, H‐J Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 4(2018) Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" ‐ The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole. Issue 2 (29th April 2017) Authors: Walsh, TJ; Moriyama, B; Penzak, SR; Klein, TE; Caudle, KE Journal: Clinical pharmacology & therapeutics Issue: Volume 102:Issue 2(2017) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗